LEADER 04506nam 2200517 450 001 9910136528903321 005 20170920010657.0 010 $a0-323-46338-X 035 $a(CKB)3710000000840764 035 $a(EBL)4658836 035 $a(MiAaPQ)EBC4658836 035 $a(EXLCZ)993710000000840764 100 $a20160908h20162016 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aNew trends in the treatment of sarcoma /$feditors, Andrea S. Porpiglia, Jeffrey M. Farma ; consulting editor, Ronald F. Martin 210 1$aPhiladelphia, Pennsylvania :$cElsevier,$d2016. 210 4$dİ2016 215 $a1 online resource (404 p.) 225 1 $aSurgical Clinics of North America,$x0039-6109 ;$vVolume 96, Number 5 300 $aDescription based upon print version of record. 311 $a0-323-46337-1 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aTitle page; Table of Contents; Copyright; Contributors; Forthcoming Issues; Foreword; Preface; Epidemiology and Etiology of Sarcomas; Key points; Introduction; Epidemiology; Etiology; Summary; Bone and Soft Tissue Pathology: Diagnostic and Prognostic Implications; Key points; Introduction; World Health Organization 2013 update; Pathologic grading of soft tissue sarcomas; Pathological staging of soft tissue sarcomas; Pathologic grading of bone tumors; Pathologic staging of bone tumors; Overview of the pathologic aspect of diagnosis, prognosis, and theranostics 327 $aMalignant soft tissue and bone tumorsSarcomas with low metastatic potential; Locally aggressive soft tissue tumors; Benign soft tissue and bone tumors; Giant cell tumors; Summary; Radiologic Approach to Bone and Soft Tissue Sarcomas; Key points; Imaging modalities; Evaluation of a newly suspected musculoskeletal tumor; Tumor staging, response to neoadjuvant therapy, and postoperative surveillance; Multimodality Management of Soft Tissue Tumors in the Extremity; Key points; Introduction; Clinical presentation and diagnosis; Imaging the primary tumor; Biopsy techniques 327 $aStaging and extent of disease work-upSurgical approach; Clinical outcomes; Multimodality treatment; Isolated limb perfusion; Follow-up; Summary; Retroperitoneal Sarcomas; Key points; Introduction; Surgery; Radiation therapy; Chemotherapy; Recurrence; Surveillance; Summary; Management of Truncal Sarcoma; Key points; Introduction; Unique considerations for truncal sarcoma; Summary; Management of Desmoids; Key points; Introduction; Evaluation; Treatment; Surveillance; Summary; Dermatofibrosarcoma Protuberans; Key points; Introduction; Epidemiology and subtypes; Genetics; Risk factors 327 $aDiagnosis and evaluationPathologic evaluation; Treatment; Metastatic disease; Follow-up and surveillance; Summary; Management of Breast Sarcoma; Key points; Clinical presentation and initial evaluation; Multidisciplinary management; Surgical management; Radiation therapy; Chemotherapy; Clinical outcomes and prognostic factors; Summary; Management of Gastrointestinal Stromal Tumors; Key points; Introduction; Molecular pathologic characteristics of gastrointestinal stromal tumor; Pathologic characteristics of gastrointestinal stromal tumor; Management of primary gastrointestinal stromal tumor 327 $aManagement of recurrent or metastatic gastrointestinal stromal tumorSummary; Management of Bone Sarcoma; Key points; Introduction; Treatment modalities; Reconstructive considerations; Summary; Pediatric Sarcomas; Key points; Rhabdomyosarcoma; Nonrhabdomyosarcoma soft tissue sarcomas; Bone sarcomas; Summary; The Role for Radiation Therapy in the Management of Sarcoma; Key points; Introduction; Amputation versus limb-sparing surgery with adjuvant radiation; Limb-sparing surgery with or without adjuvant radiation; Preoperative versus postoperative radiotherapy 327 $aImage guidance and intensity-modulated radiotherapy 410 0$aSurgical clinics of North America ;$vVolume 96, Number 5. 606 $aSarcoma$xTreatment 615 0$aSarcoma$xTreatment. 676 $a616.994 702 $aPorpiglia$b Andrea S. 702 $aFarma$b Jeffrey M. 702 $aMartin$b Ronald F. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910136528903321 996 $aNew trends in the treatment of sarcoma$93400530 997 $aUNINA